TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study

被引：0
|
作者：
Jolanta Kupryjanczyk
Ewa Kraszewska
Izabela Ziolkowska-Seta
Radoslaw Madry
Agnieszka Timorek
Janina Markowska
Jerzy Stelmachow
Mariusz Bidzinski
机构：
[1] the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,Department of Molecular Pathology
[2] Medical Center for Postgraduate Education,Department of Gastroenterology and Hepatology
[3] the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,Department of Gynecologic Oncology
[4] Warsaw Medical University and Brodnowski Hospital,Department of Pathology, IInd Faculty of Medicine
[5] Medical University,Chair of Gynecologic Oncology
[6] Warsaw Medical University and Brodnowski Hospital,Chair and Department of Obstetrics, Gynecology and Oncology, IInd Faculty of Medicine
来源：
BMC Cancer | / 8卷
关键词：
Ovarian Cancer Patient; Clear Cell Carcinoma; Poor Tumor Differentiation; TP53 Status; TP53 Protein;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study
    Kupryjanczyk, Jolanta
    Kraszewska, Ewa
    Ziolkowska-Seta, Izabela
    Madry, Radoslaw
    Timorek, Agnieszka
    Markowska, Janina
    Stelmachow, Jerzy
    Bidzinski, Mariusz
    BMC CANCER, 2008, 8 (1)
  • [2] Profiles of ovarian cancer patients that benefit from taxane-platinum and platinum-based chemotherapy
    Markowska, J.
    Bidziaski, M.
    Stelmachow, J.
    Kraszewska, E.
    Ziolkowska-Seta, I.
    Madry, R.
    Timorek, A.
    Rembiszewska, A.
    Kupryjaaczyk, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] TP53, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-platinum regimens
    Ziolkowska-Seta, Izabela
    Madry, Radoslaw
    Kraszewska, Ewa
    Szymanska, Teresa
    Timorek, Agnieszka
    Rembiszewska, Alina
    Kupryjanczyk, Jolanta
    GYNECOLOGIC ONCOLOGY, 2009, 112 (01) : 179 - 184
  • [4] TP53 gene status in patients with advanced ovarian cancer in relation to response to paclitaxel plus platinum-based chemotherapy
    Hardisson, D.
    Mendiola, M.
    Marino, A.
    Dominguez-Caceres, A.
    Hernandez-Cortes, G.
    Suarez, A.
    Palacios, J.
    MODERN PATHOLOGY, 2007, 20 : 200A - 200A
  • [5] TP53 gene status in patients with advanced ovarian cancer in relation to response to paclitaxel plus platinum-based chemotherapy
    Hardisson, D.
    Mendiola, M.
    Marino, A.
    Dominguez-Caceres, A.
    Hernandez-Cortes, G.
    Suarez, A.
    Palacios, J.
    LABORATORY INVESTIGATION, 2007, 87 : 200A - 200A
  • [6] Comparative effectiveness of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer
    Xianglin L. Du
    Rohan C. Parikh
    David R. Lairson
    Sharon H. Giordano
    Putao Cen
    Medical Oncology, 2013, 30
  • [7] Comparative effectiveness of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer
    Du, Xianglin L.
    Parikh, Rohan C.
    Lairson, David R.
    Giordano, Sharon H.
    Cen, Putao
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [8] TP53 gene status and human papilloma virus infection in response to platinum plus taxane-based chemotherapy of epithelial ovarian carcinomas
    Malisic, E.
    Jankovic, R.
    Jakovljevic, K.
    Radulovic, S.
    JOURNAL OF BUON, 2011, 16 (04): : 701 - 707
  • [9] TP53 mutation screening in patients with recurrent platinum-sensitive ovarian cancer.
    Brana, Irene
    Moore, Kathleen
    Welch, Stephen
    Shapira-Frommer, Ronnie
    Gibbon, Darlene
    Hirte, Hal
    Rivkin, Saul
    Coleman, Robert
    Prendergast, Gerry
    Moxley, Katherine M.
    Jou, Ying-Ming
    Marinucci, Michelle
    Freshwater, Tomoko
    McCarthy, Sharon
    Anthony, Mark Lee
    Rose, Shelonitda
    Oza, Amit M.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [10] Cost-Utility Analysis of Platinum-Based Chemotherapy versus Taxane and Other Regimens for Ovarian Cancer
    Lairson, David R.
    Parikh, Rohan C.
    Cormier, Janice N.
    Du, Xianglin L.
    VALUE IN HEALTH, 2014, 17 (01) : 34 - 42
12345